SCHEMBL6409638

SCHEMBL6409638

Sc1nnc(CNc2cccc(Cl)c2)n1CCc1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.63
TSHR P16473 3/20 0.56
LMNA P02545 2/20 0.56
GAA P10253 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
ATM Q13315 1/20 0.44
MAPT P10636 4/20 0.42
CASP3 P42574 1/20 0.42
SENP8 Q96LD8 1/20 0.42
SENP7 Q9BQF6 1/20 0.42
SENP6 Q9GZR1 1/20 0.42
NPSR1 Q6W5P4 2/20 0.41
HSP90AA1 P07900 2/20 0.41
HTT P42858 1/20 0.41
SRC P12931 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
KDM4E B2RXH2 1/20 0.40
NTRK1 P04629 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6408598 0.82 LMNA (0.61) ALDH1A1TSHRLMNAGAASMN1; SMN2
SCHEMBL6403533 0.78 ALDH1A1 (0.55) ALDH1A1TSHRLMNAGAASMN1; SMN2
SCHEMBL6403358 0.75 TSHR (0.61) ALDH1A1TSHRLMNAGAASMN1; SMN2
SCHEMBL1104371 0.74 L3MBTL1 (0.48) ALDH1A1TSHRGAASMN1; SMN2MAPT
SCHEMBL14557026 0.74 POLB (0.43) ALDH1A1LMNASMN1; SMN2MAPTHTT
SCHEMBL631634 0.72 LMNA (0.59) ALDH1A1TSHRLMNAGAASMN1; SMN2
SCHEMBL14204006 0.71 POLB (0.55) ALDH1A1LMNAMAPTNPSR1HTT
SCHEMBL14557021 0.71 POLB (0.41) ALDH1A1LMNASMN1; SMN2MAPTHTT
SCHEMBL6405215 0.71 GAA (0.62) ALDH1A1TSHRLMNAGAASMN1; SMN2
Hydrochloric Acid SCHEMBL7102271 0.70 LMNA (0.58) ALDH1A1TSHRLMNAGAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof AGRIUS GROUP, LLC. 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof ABCG2, ATP5ME, DNTT ALDH1A1 720/4885TSHR 3470/4885LMNA 4116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.